Phylagen Receives Rigorous AOAC Validation for COVID-19 Indoor Testâ„¢

▴ Phylagen Receives Rigorous AOAC Validation for COVID-19 Indoor Testâ„¢
Phylagen recently awarded a Certificate of Validation from AOAC INTERNATIONAL for its COVID-19 Indoor Testâ„¢ that detects SARS-CoV-2 in any built environment.

Phylagen, the San Francisco-based biotech company focused on decoding the environmental microbiome for indoor safety was recently awarded a Certificate of Validation from AOAC INTERNATIONAL for its COVID-19 Indoor Test™ that detects SARS-CoV-2 in any built environment. Phylagen's test is one of the first to pass the rigorous independent evaluation required by the AOAC Research Institute's Performance Tested Methods™ Program and is currently the only certified SARS-CoV-2 indoor test kit solution available for anyone to purchase directly online.

Phylagen partnered with AOAC INTERNATIONAL at the beginning of the pandemic to be one of the first companies to undergo the rigorous test. During this initial validation process, the Phylagen COVID-19 Indoor Test™ and two other kits were evaluated for detection of the virus. To date, there has been no third-party certification available for indoor environmental testing.

"The rigor the AOAC brings makes it significant for Phylagen to be among the first cohort to receive AOAC's new Certificate of Validation for environmental testing of SARS-CoV-2," said Dr. Brad Taft, Ph.D., Chief Scientific Officer, Phylagen. "The emergence of the AOAC certification reinforces that indoor environmental testing for early detection of COVID-19 is becoming an evermore ubiquitous and essential tool for keeping populations in shared spaces safe."

The COVID-19 Indoor Test™ by Phylagen is a SARS-CoV-2 quantitative detection method that extracts the SARS-CoV-2 RNA from environmental swabs and detects it utilizing RT- PCR technology. Environmental surface swabs are collected by the customer and shipped back to Phylagen, Inc. for sample processing. Sample data are analyzed, and results are reported through a tracking portal.

Since the start of the pandemic, a wide range of businesses has turned to Phylagen to protect their workers by implementing regular indoor environmental testing. Manufacturing facilities shared workspaces, schools, and assisted living homes are just some of the businesses that have partnered with Phylagen to identify the presence of COVID-19.  The COVID-19 Indoor Test™ can be purchased online starting at $189 for five swabs. Custom solutions are also available for purchase. Once Phylagen receives the completed test swabs, results are delivered within 24 hours.  

About Phylagen

Phylagen is a San Francisco based biotech company committed to unlocking the global microbiome of built spaces. Phylagen's internationally recognized team of scientists turn dust into genomic data, providing crucial microbiome insights that impact indoor building health, supply chain traceability, and more.

Tags : #Phylagen #SANFRANCISCO #biotechcompany #AOACINTERNATIONAL #CertificateofValidation #Award #COVID-19IndoorTest #SARS-CoV-2 #ResearchInstitutesPerformanceTestedMethods #Covid-19Test #Covid-19Patients #DailyCovidUpdates

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

10 PCOS Warning Signs That Need Your AttentionDecember 27, 2024
Experts Dub 2024 as the Year of Technologies and Innovations in Healthcare; Stress on further Integration of Technologies December 27, 2024
Aakash Healthcare Partners with Japan for Groundbreaking Surgical Intervention: A Global Collaboration to Revolutionize Cardiovascular CareDecember 26, 2024
Traditional Medicine Goes Global: How Ayush 2024 Reimagined WellnessDecember 26, 2024
Aster Guardians Global Nursing Award 2025 worth INR 2 Crore now open for nominations worldwide December 26, 2024
Holiday Season Round the Corner? 6 Daily Habits That Could Be The Reason Behind Your Fatty LiverDecember 26, 2024
Healing the Nation: Doctors as Architects of a Healthier FutureDecember 26, 2024
Brewing Health Benefits: Can Coffee and Tea Help Fight Head and Neck Cancers?December 26, 2024
Seven-Year-Old Fights Back Against Rare Autoimmune DiseaseDecember 26, 2024
Olympus Named to Dow Jones Sustainability World Index for the Fourth Consecutive YearDecember 26, 2024
American Oncology Institute (AOI) in Nagpur Restores Mobility with KyphoplastyDecember 26, 2024
Sanjeevani Healthcare & Wellness Expo 2024: A Dynamic Platform for Global Healthcare CollaborationDecember 23, 2024
Ranitidine: Saviour or Suspect? The Truth Behind the Stomach Acid RemedyDecember 23, 2024
From One-Size-Fits-All to Precision Medicine: The New Hope for Rare Bone Cancer PatientsDecember 23, 2024
World Meditation Day: India’s Gift of Peace to a Chaotic WorldDecember 23, 2024
Breaking New Ground in Migraine Care: A Landmark Session on Diagnosis and TreatmentDecember 23, 2024
Black Angels remind us of centuries of injustices plaguing the TB responseDecember 20, 2024
Healthcare Startups to Watch Out for in 2025December 20, 2024
Biobank Blueprint: Redefining Diabetes Diagnosis and Treatment in IndiaDecember 20, 2024
The Future of Malaria Prevention: Can This Vaccine Eliminate the Disease?December 20, 2024